SE467542B - Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar - Google Patents

Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Info

Publication number
SE467542B
SE467542B SE8902148A SE8902148A SE467542B SE 467542 B SE467542 B SE 467542B SE 8902148 A SE8902148 A SE 8902148A SE 8902148 A SE8902148 A SE 8902148A SE 467542 B SE467542 B SE 467542B
Authority
SE
Sweden
Prior art keywords
ser
leu
pro
lys
arg
Prior art date
Application number
SE8902148A
Other languages
English (en)
Swedish (sv)
Other versions
SE8902148D0 (sv
SE8902148L (sv
Inventor
A Vahlne
Original Assignee
Syntello Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Ab filed Critical Syntello Ab
Priority to SE8902148A priority Critical patent/SE467542B/sv
Publication of SE8902148D0 publication Critical patent/SE8902148D0/xx
Priority to AU59453/90A priority patent/AU638727B2/en
Priority to EP90917762A priority patent/EP0477301A1/de
Priority to EP97103408A priority patent/EP0814090A1/de
Priority to PCT/SE1990/000407 priority patent/WO1990015820A1/en
Priority to FI915702A priority patent/FI915702A0/fi
Priority to CA002062713A priority patent/CA2062713A1/en
Priority to KR1019910701844A priority patent/KR0151860B1/ko
Priority to JP2509469A priority patent/JP2650217B2/ja
Priority to HU906639A priority patent/HUT61323A/hu
Priority to ZA904565A priority patent/ZA904565B/xx
Priority to NZ234049A priority patent/NZ234049A/xx
Publication of SE8902148L publication Critical patent/SE8902148L/xx
Priority to NO91914755A priority patent/NO914755L/no
Publication of SE467542B publication Critical patent/SE467542B/sv
Priority to AU48906/93A priority patent/AU654240B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8902148A 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar SE467542B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
HU906639A HUT61323A (en) 1989-06-13 1990-06-12 And treating htlv-1 peptides and antibodies against them for diagnosting htlv-1 infection and for vaccination against it
CA002062713A CA2062713A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
JP2509469A JP2650217B2 (ja) 1989-06-13 1990-06-12 Ｈｔｌｖ―１感染の診断、治療及び予防接種のためのペプチド
EP97103408A EP0814090A1 (de) 1989-06-13 1990-06-12 Peptide und Antikörper die davon abgeleitet sind zur Diagnose von, Therapie und Impfung gegen HTLV-1 Infektionen
PCT/SE1990/000407 WO1990015820A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
FI915702A FI915702A0 (fi) 1989-06-13 1990-06-12 Peptider och daerav erhaollna antikroppar foer diagnos av vaccination emot htlv-1 infektion.
AU59453/90A AU638727B2 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
KR1019910701844A KR0151860B1 (ko) 1989-06-13 1990-06-12 Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로부터 유도된 항체
EP90917762A EP0477301A1 (de) 1989-06-13 1990-06-12 Peptide oder davon abgeleitete antikörper zur diagnose von, zur therapie, und zur einimpfung gegen htlv-1-infektion
NZ234049A NZ234049A (en) 1989-06-13 1990-06-13 Peptide epitopes of, and antibodies to htlv-1
ZA904565A ZA904565B (en) 1989-06-13 1990-06-13 Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
NO91914755A NO914755L (no) 1989-06-13 1991-12-04 Peptider og derav deriverte motstoffer for diagnose av, terapi for og vaksinasjon mot htlv-1 infeksjon
AU48906/93A AU654240B2 (en) 1989-06-13 1993-10-08 A method of eliciting the production of antibodies against HTLV-1 in mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Publications (3)

Publication Number Publication Date
SE8902148D0 SE8902148D0 (sv) 1989-06-13
SE8902148L SE8902148L (sv) 1990-12-14
SE467542B true SE467542B (sv) 1992-08-03

Family

ID=20376281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Country Status (11)

Country Link
EP (2) EP0814090A1 (de)
JP (1) JP2650217B2 (de)
KR (1) KR0151860B1 (de)
AU (2) AU638727B2 (de)
CA (1) CA2062713A1 (de)
FI (1) FI915702A0 (de)
HU (1) HUT61323A (de)
NZ (1) NZ234049A (de)
SE (1) SE467542B (de)
WO (1) WO1990015820A1 (de)
ZA (1) ZA904565B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
FI910245L (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
AU641554B2 (en) * 1990-08-29 1993-09-23 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5849475A (en) * 1990-10-12 1998-12-15 Benjamin Rovinski et al Immunoassay diagnostic kit containing antigens derived from self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JP3421336B2 (ja) * 1991-07-10 2003-06-30 アボツト・ラボラトリーズ 合成ペプチドを用いてのｈｔｌｖ−▲ｉ▼とｈｔｌｖ−▲ｉｉ▼との区別
CA2117378C (en) * 1992-02-24 2003-04-15 Steven K. H. Foung Htlv-i/htlv-ii assay and method
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
JPH09510009A (ja) * 1993-12-20 1997-10-07 アボツト・ラボラトリーズ 合成ペプチドを用いるｈｔｌｖ−ｉおよびｈｔｌｖ−ｉｉの識別
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
JP2015215244A (ja) * 2014-05-12 2015-12-03 富士レビオ株式会社 免疫測定における抗ｈｔｌｖ抗体の検出感度を向上させる方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572800A (en) * 1982-09-30 1986-02-25 Otsuka Pharmaceutical Co., Ltd. Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
US4525300A (en) * 1983-01-07 1985-06-25 Japanese Foundation For Cancer Research Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
JPS6028993A (ja) * 1983-07-22 1985-02-14 Otsuka Pharmaceut Co Ltd ヒト白血病ウイルス関連ペプチド
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
WO1989006543A1 (en) * 1988-01-12 1989-07-27 Genelabs Incorporated Htlv-i peptide antigen and assay
JPH02209889A (ja) * 1988-02-08 1990-08-21 Univ Duke 合成親水性ペプチド
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
JPH0628993A (ja) * 1992-07-10 1994-02-04 Fujitsu Ltd 電子ビーム装置

Also Published As

Publication number Publication date
AU638727B2 (en) 1993-07-08
AU5945390A (en) 1991-01-08
HUT61323A (en) 1992-12-28
JPH04506077A (ja) 1992-10-22
SE8902148D0 (sv) 1989-06-13
WO1990015820A1 (en) 1990-12-27
HU906639D0 (en) 1992-02-28
KR920702688A (ko) 1992-10-06
AU4890693A (en) 1993-12-16
EP0477301A1 (de) 1992-04-01
AU654240B2 (en) 1994-10-27
SE8902148L (sv) 1990-12-14
JP2650217B2 (ja) 1997-09-03
FI915702A7 (fi) 1991-12-03
KR0151860B1 (ko) 1998-10-01
NZ234049A (en) 1993-02-25
ZA904565B (en) 1991-03-27
FI915702A0 (fi) 1991-12-03
CA2062713A1 (en) 1990-12-14
EP0814090A1 (de) 1997-12-29

Similar Documents

Publication Publication Date Title
US5017687A (en) Peptides for the detection of HTLV-1 infection
US4812556A (en) Synthetic peptide antigen for the detection of HIV-2 infection
AU606928B2 (en) Synthetic peptide antigens for the detection of hiv-1 infection
US6406841B1 (en) Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
AU2009213045B2 (en) Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
JP4097162B2 (ja) Ｈｃｖ−特異的ペプチド、それらのための剤およびそれらの使用
EP0247557B1 (de) HTLV-III(LAV)Decke-Peptide
SE467542B (sv) Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
JPH04210999A (ja) Ｈｉｖウイルス類のエンベロープ糖タンパク質由来のペプチド、これらのウイルスによって起こる感染の検出とエイズ症に対する予防接種へのこれらペプチドの用途
US6531574B1 (en) T-lymphotrophic virus
EP0317804B1 (de) HIV-Peptide und Methoden für den Nachweis von HIV
US5283320A (en) Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
Sibille et al. Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats
Norrby et al. Immunochemistry of the dominating antigenic region Ala582 to Cys604 in the transmembranous protein of simian and human immunodeficiency virus.
CA1338001C (en) Synthetic peptide antigens for the detection of htlv-1 infection
CA1338028C (en) Synthetic peptide antigens for the detection of hiv-1 infection
RU1825424C (ru) Способ обнаружени антител к ВИЧ-2
Virovahl Vahlne et al.
AU780017B2 (en) Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
JPH0215098A (ja) Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法
JPH01163198A (ja) Ｈｉｖ−２感染検出用合成ペプチド抗原、その組成物およびその使用方法
JPS63501295A (ja) Ｔ−リンパ趨行性ウイルス
HK1006921A (en) Peptides and antibodies derived therefrom for the diagnosis of , therapy for and vaccination against htlv-1 infection

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8902148-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8902148-9

Format of ref document f/p: F